While previous studies have linked commercial dietary supplements like nicotinamide riboside (NR), a form of vitamin B3, to benefits related to cardiovascular, metabolic and neurological health, new research from the University of Missouri has found NR could actually increase the risk of ser
Coimbatore (Tamil Nadu) [India], November 11 (ANI/BusinessWire India): A survey by the United Nations showed Indians get addicted in their early teens be it over drugs, alcohol, or any other controlled substance. Consuming any form of these addictive substances creates a pleasurable "high" t
The estimated value of the seized drug is Rs 58 crore in the international market, and it was seized from a four-wheeler in the Luangmual area of Aizawl, and arrested two persons," Police said.
Researchers found that how pills can help cancer and diabetic patients to manage their ailments instead of needles and injections. UCR scientists have created a chemical "tag" that can be added to these drugs, allowing them to enter blood circulation via the intestines.
According to Mizoram Police, based on intelligence input, Lunglei District Special Branch (DSB) team on Wednesday conducted an operation between Tlawng bridge - Pukpui and seized 1.747 kg of heroin, valued at Rs 8.735 crore in the international market, from the possession of two persons name
According to a recent investigation that was published in the Journal of Internal Medicine, among young US citizens between the ages of 15 and 44, the chance of dying from infectious endocarditis has increased by a factor of two over the past two decades.
A nutrient that is common in the human diet has been found to aid the survival of a cancer-causing bacterium, a new Yale study finds. The findings could reveal an important target for new drugs to tackle numerous infectious diseases in humans.
A new drug called Baxdrostat has been shown to significantly reduce high blood pressure (hypertension) in patients who may not respond to current treatments for the condition, according to results from a phase II trial led jointly by a Queen Mary University of London researcher and colleague